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Introduction
The VD Fact Sheet is intended as a handy source of basic statistics on the venereal 
diseases in the United States. In this booklet, public health specialists, students, physicians, 
and other persons interested in medical data will find venereal diseases measured by incidence 
and prevalence. The general public will find tables showing the costs of uncontrolled venereal 
disease and the frequency of psychoses and deaths from syphilis. While the results of case- 
finding are measured in terms of cases reported, the actual amount of casefinding effort is 
seen in the volume of diagnostic examinations and epidemiologic activity. As there is no agent 
for immunizing the population, finding and treating cases continues to be the only feasible means 
of controlling venereal disease.
Facts on these aspects of the venereal disease problem and program are presented in the 
text and tables which follow. The Information is current as of the date of publication, and it 
supersedes any previously published data. Where no source is cited, the data presented are 
based on the statistics collected by the Venereal Disease Program of the National Communicable 
Disease Center, or upon estimates made by the Program. Where data are indicated as being 
for “ fiscal years,” the period runs from July 1 of the previous year through June 30 of the year 
indicated on the table. Rates per 100,000 population shown in this Fact Sheet are based on 
appropriate population estimates obtained from the Bureau of the Census.
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Incidence and Prevalence
The incidence of syphilis is defined as the number of new cases occurring in a given 
area within a specified period of time, usually a year.
Since the symptoms of primary and secondary syphilis appear soon after the disease is 
acquired, the number of primary and secondary cases occurring in the population within a given 
period of time would be the same as the incidence of syphilis.
Cases of primary and secondary syphilis are reportable by law in all of the 50 States and 
the District of Columbia. In the fiscal year ending June 30, 1968, physicians and clinics in the 
United States reported 20,182 cases to State or local departments of health. But the number of 
cases reported understates actual incidence for two reasons:
1. Not all cases are diagnosed, and
2. Not all diagnosed cases are reported.
The Venereal Disease Program currently estimates that the actual occurrence of syphilis 
was about 80,000 cases in Fiscal Year 1968 of which 20,182 were diagnosed and reported to 
health departments.
Cases of syphilis which occur but go untreated cumulate to form a large reservoir of 
cases needing treatment. This reservoir of cases needing treatment (prevalence), most of 
which are in the latent stage of disease and are detectable only by means of bloodtests, is 
currently estimated to number about 636,000.
Gonorrhea is underreported for the same reasons given above for the underreporting 
of syphilis but the problem of underdiagnosis is more acute in females than males due to the 
frequent asymptomatic nature of disease in the female. The Venereal Disease Program 
estimates that at least 1,400,000 cases of gonorrhea occurred in the United States in Fiscal 
Year 1968, of which 431,380 were diagnosed and reported to health departments.
Costs of Uncontrolled Syphilis
The statistics presented in Table 1 (next page) indicate the toll imposed by syphilis upon 
the manpower and economy of the country.
The estimate of man-years of disability for institutionalization of the syphilitic insane is 
based on the total number of patients in mental institutions and upon the proportion of those 
diagnosed as having syphilitic psychoses. Patients in State, county, and Veterans Administration 
hospitals for the permanent care of the insane are included.
The cost of maintenance is based upon the number of patients with syphilitic psychoses 
in tax supported institutions and upon the average per patient maintenance cost. Approximately 
three percent of patients with syphilitic psychoses are maintained in private institutions and 
these have not been included in this report.
Disability attributed to cardiovascular syphilis and to locomotor ataxia is based on 
conservative estimates of the prevalence of these late manifestations of syphilis.
The loss of life expectancy indicates the loss of future years of life for persons dying of 
syphilis in 1966. The loss of life expectancy is based on the expected years of life remaining 
to persons of that age, color and sex. The loss of income is based on projected earnings of 
these persons for the productive years of life lost to age 65. The estimated earnings are based 
on the median total money income rate for adults for 1966.
While disabilities and deaths from syphilis have been diminishing in recent years, costs 
and losses per case have been rising. Asa result, total costs and income losses from syphilitic 
disabilities and deaths remain high compared to previous estimates.
On the basis of findings of research conducted in Macon County, Alabama, it has been 
estimated that the life expectancy of a Negro male between the ages of 25 and 60 years, infected 
with syphilis and receiving no appreciable treatment for his infection, is reduced by about 17 
percent.*
♦Shafer, J .K .;  Usilton. L ida  J .;  G leeson, Geraldine A.: Untreated Syph ilis  in the Male Negro: A prospective study 
of the effeet on life expectancy. Pub lic  Health Reports. 69:6b>4-690. Ju ly  1951. M ilbank Memorial Fund Quarterly. 
32:262-274. Ju ly  1954.
TABLE 1
ESTIMATED ANNUAL COSTS OF UNCONTROLLED SYPHILIS 
UNITED STATES, 1966*
MAN-YEARS OF SYPHILIS DISABILITY PER YEAR
Institutionalization for syphilitic insanity .............................  13,651
Disability from cardiovascular syphilis including aneurysm (est.) . . 7,000
Disability from syphilitic blindness .......................................  5,040
ECONOMIC COSTS OF SYPHILITIC PSYCHOSES 
AND SYPHILITIC BLINDNESS PER YEAR
Maintenance of patients with syphilitic psychoses ......................  $43,719,000
Compensation to syphilitic blind ............................................  $ 5,443,000
LOSS OF LIFE EXPECTANCY FROM DEATHS DUE TO SYPHILIS IN MAN-YEARS
White males .....................................................................  16,231
White f e m a l e s ..................................................................  6,514
Non-white males ................................................................ 5,497
Non-white females 3,942
Total population ................................................................  32,184
LOSS OF INCOME TO AGE 65 AT 1966 MEDIAN TOTAL MONEY INCOME RATE ............  $ 3 3 ,3 3 5 ,0 0 0
*Estimates based on most recent year (1966) for which data is available.
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Reported Mortality and Insanity 
Due to Syphilis
Mortality statistics are processed and tabulated in the National Center for Health 
Statistics (NCHS) from microfilm copies of the original certificates filed with State or local 
registrars. Mortality rates for syphilis are calculated by dividing the number of deaths in a given 
year by the population for that year and multiplying by 100,000 (rate per 100,000  population).
The infant mortality rate for syphilis for a given year is obtained by dividing the number 
of deaths due to syphilis among children under one year of age by the number of live births 
in the year multiplied by 10,000 (rate per 10,000 live births).
Since deaths from syphilis represent casefinding and treatment failures, mortality due to 
syphilis may be considered an inverse measure of the success of the syphilis control program.
It has been the practice since 1900 to revise the International Lists of Diseases and Causes 
of Death about every 10 years to keep abreast of medical progress. These revisions have at 
times affected the continuity of syphilis mortality statistics. “The Sixth Revision of the Inter­
national Lists of Causes of Death,” which became effective In 1949, reduced reported syphilis 
deaths by about 26 percent. In “The Seventh Revision of the International Lists of Causes of 
Death,” which was published in 1955 and became effective beginning January 1958, an increase 
of 3.3 percent for syphilis and its sequelae occurred by reason of a change in interpretation 
of “ aneurysm of the aorta” reported in a sequence involving arteriosclerosis of sites other than 
the aorta. It should be noted, however, that the interpretation of such sequences reverted in 
1959 to that used with the Sixth Revision. Mortality rates given in this FACT SHEET have been 
adjusted to the basis of the Seventh Revision. No adjustment was made for infant mortality 
since it was affected very little by changes in the Seventh Revision.
Insanity due to syphilis is measured by the rate of first admissions to mental hospitals 
because of syphilis. Excluded are first admissions to psychopathic hospitals which provide only 
temporary care, and admissions to Veterans Administration facilities. The number of admis­
sions is obtained from “ Patients in Mental Institutions” published by the National Institute 
of Mental Health. Since only first admissions are Included In the rate, the figures over a period 
of years represent a measure of the trend of incidence of syphilitic insanity.
Data on mortality and insanity due to syphilis are presented in Table 2 (next page).
TABLE 2




Year SYPHILIS MORTALITY* INFANT MORTALITY DUE TO SYPHILIS
FIRST ADMISSIONS TO 
MENTAL HOSPITALS 
DUE TO SYPHILIS
Total Rate Per 100,000 Pop. Total Rate Per 10,000 Live Births Rate/100,000 P o p .**
Number Total White Nonwhite Number Total White Nonwhite Number Rate
1940 14,064 10.7 7.3 40.2 1,251 5.30 2.50 25.20 7,694 6.1
1945 10,406 7.9 5.6 27.3 684 2.50 1.07 12.59 6,897 5.5
1950 7,568 5.0 3.7 16.1 201 .57 .24 2.59 3,751 2.6
1951 6,274 4.1 3.0 13.4 129 .34 .12 1.73 3,035 2.1
1952 5,719 3.7 2.7 11.4 92 .24 .10 1.14 2,602 1.8
1953 5,273 3.3 2.4 10.9 56 .14 .04 .77 2,360 1.5
1954 4,835 3.0 2.3 9.2 43 .11 .03 .54 2,145 1.3
1955 3,834 2.4 1.7 7.9 34 .08 .03 .41 1,663 1.0
1956 3,870 2.3 1.7 7.1 30 .06 .02 .31 1,373 .8
1957 3,825 2.2 1.7 6.9 20 .06 .05 .16 1,307 .8
1958 3,469 2.0 1.5 6.4 29 .07 .02 .36 1,321 .6
1959 3,069 1.7 1.3 4.9 19 .06 .02 .23 774 .4
1960 2,945 1.6 1.3 4.5 30 .07 .04 .24 742 .4
1961 2,850 1.6 1.2 4.5 20 .05 .02 .18 639 .3
1962 2,811 1.5 1.2 3.9 29 .07 .02 .33 452 .2
1963 2,666 1.4 1.1 3.5 19 .07 .01 .22 312 .1
1964 2,619 1.4 1.1 3.2 20 .05 .02 .18 260 .1
1965 2,434 1.3 1.1 2.7 25 .07 .04 .22 232 . 1
1966 2,193 1.1 1.0 2.2 25 .07 .03 .28 N.A. N.A.
1967*** 2,445 1.2 N. A. N.A. N.A. N.A. N.A. N.A. N.A. N.A.
* Seventh Revision, International Lists of Causes of Death, 1955; see Mortality, Page 5 for explanation.
** Does not include admissions to Veterans Administration and psychopathic hospitals; rate based on population of 
area reporting.
*** Estimated.
N.A.: Not Available Source: Mortality and Natality Data, National Vital Statistics Division; First
Admissions to Mental Hospitals, National Institute of Mental Health;
Rates based on population estimates of the Bureau of the Census.
Reported Cases of Venereal Disease
All states require that each case of syphilis and gonorrhea which comes to medical atten­
tion be reported to the state or local health officer. The other venereal diseases are also 
reportable in most states. Every three months, each state submits to the Public Health Service 
a statistical summary of cases reported during the quarter. All cases not previously reported 
in the state, regardless of duration of infection or previous treatment status, are to be counted 
in the statistical report of cases. Reported morbidity, as reported cases are sometimes called, 
indicates the volume of successful casefinding.
The trend of reported cases or case rates of early syphilis over a period of years may be 
indicative of incidence trends if no significant changes in casefinding efforts or completeness 
of case reporting have occurred. Similiarly, the trend of reported cases of syphilis in all stages 
of disease can be interpreted as indicative of prevalence trends subject to the limitations 
imposed by changes in casefinding efforts and completeness of case reporting. For these 
reasons, trends in reported cases and rates must be interpreted with caution since changes in 
casefinding efforts and completeness of case reporting are reflected in morbidity data just as 
much as changes in disease incidence and prevalence.
Reported venereal disease cases and rates are shown in Tables 3 through 8 .
Table 4 shows that syphilis in all stages decreased from 575,593 cases in Fiscal Year 1943 
to 98,195 cases in 1968. This decrease in cases is interpreted as indicative of a decrease in 
prevalence over the last 25 years.
The trend of cases in the primary and secondary stage of syphilis, usually interpreted as 
paralleling the actual occurrence of syphilis, has changed direction four times during the 27 
years these data have been available (Table 4). Primary and secondary syphilis increased during 
and shortly after World War II to a peak of 106,539 cases in Fiscal year 1947; cases then de­
creased rapidly to a low of 6,251 cases in Fiscal Year 1957. After 1957, cases increased again 
to a peak of 23,250 in Fiscal Year 1965. Since 1965, small decreases have been reported each 
year.
The trend of reported cases of gonorrhea in the United States (Table 4) closely followed 
the trend of early syphilis from Fiscal Year 1941 through Fiscal Year 1965 in direction but not 
in magnitude of change. Whereas early syphilis cases began to decline in Fiscal Year 1966, 
gonorrhea cases continued to increase. Reported cases of gonorrhea have increased from 
216,476 cases in Fiscal Year 1957 to431,380 cases in Fiscal Year 1968, an all-time high number 
for this disease.
Table 5 shows that most of the congenital syphilis which has been reported in recent years 
is among adults and reflects the high incidence of syphilis 20 or more years ago. Cases diag­
nosed among infants increased between Fiscal Years 1957 and 1965 in tandem with the increase 
in acquired (primary and secondary) syphilis but remains at a relatively low level.
Table 6 shows geographic variations in the reported case rates of venereal disease.
Tables 7 and 8 show the age distribution of newly acquired venereal disease. These tables 
show that the 20-24 year-old age group has the highest risk of acquiring venereal disease; 
for males, the reported risk of acquiring gonorrhea is higher than for females. The difference 
between sexes in reported rates of gonorrhea may result from failure to diagnose the disease 
in females because of the greater frequency of asymptomatic disease in females. The gonorrhea 
rate for males age 20-24 in Calendar Year 1967 was 1,830 cases per 100,000 males, or one 
reported case for every 55 males in this age group.
The difference in reported cases and rates between color groups shown in Tables 7 and 8 
may be biased because nonwhites tend to utilize public diagnostic and treatment facilities where 
reporting is complete and whites tend to seek treatment at private diagnostic facilities where 
reporting is not complete.
TABLE 3
CASES OF SYPHILIS AND GONORRHEA REPORTED TO THE PUBLIC HEALTH SERVICE 
BY STATE HEALTH DEPARTMENTS, AND RATES PER 100,000 POPULATION 
All Reporting Areas in United States 
Fiscal Years 1919-1940
Fiscal ALL STAGES OF SYPHILIS GONORRHEA
Year Cases Rates Cases Rates
1919 100,466 113o 2 131,193 147.8
1920 142,869 145.3 172,387 175.4
1921 184,090 172.3 189,927 177.7
1922 171,824 157.7 152,959 140.4
1923 172,258 156.2 156,826 142.2
1924 194,936 174.2 161,676 144.5
1925 201,692 181.2 166,208 149.3
1926 205,595 196.1 164,808 157.2
1927 196,457 171.9 160,793 140.7
1928 185,437 174.2 147,219 138.3
1929 195,559 169.2 156,544 135.4
1930 213,309 185.4 155,875 135.5
1931 229,720 197.4 155,895 134.0
1932 242,128 208.2 154,051 132.5
1933 238,656 193.4 149,823 121.4
1934 231,129 186.7 153,542 124.1
1935 255,856 205.6 162,763 130.8
1936 267,717 212.6 163,465 129.8
1937 336,258 264.3 182,460 143.4
1938 480,140 372.0 198,439 153.8
1939 478,738 367.1 182,314 139.8
1940 472,900 359.7 175,841 133.8
NOTE: Beginning in 1939, all States are included in the reporting area.
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TABLE 4
CASES OF VENEREAL DISEASE REPORTED TO THE PUBLIC HEALTH SERVICE BY 
STATE HEALTH DEPARTMENTS, AND RATES PER 100,000 POPULATION 
Fiscal Years 1941-1968 
(Known Military Cases Excluded)
United States


















Cases Rates Cases Rates Cases Rates Cases Rates Cases Rates Cases Rates Cases Rates Cases Rates Cases Rates
1941 485,560 368.2 68,231 51.7 109,018 82.6 202,984 153.9 17,600 13.4 193,468 146.7 3,384 2.5 639 .4 1,381 1.0
1942 479,601 363.4 75,312 57.0 116,245 88.0 202,064 153.1 16,918 12.8 212,403 160.9 5,477 4.1 1,278 .9 1,888 1.4
1943 575,593 447.0 82,204 63.8 149,390 116.0 251,958 195.7 16,164 12.6 275,070 213.6 8,354 6.4 1 ,748 1.3 2,593 2.0
1944 467,755 367.9 78,443 61.6 123,038 96.7 202,848 159.6 13,578 10.7 300,676 236.5 7,878 6.1 1,759 1.3 2,858 2.2
1945 359,114 282.3 77,007 60.5 101,719 79.9 142,187 111.8 12,339 9.7 287,181 225.8 5,515 4.3 1,857 1.4 2,631 2.0
1946 363,647 271.7 94,957 70.9 107,924 80.6 125,248 93.6 12,106 9.0 368,020 275.0 7,091 5.2 2 ,232 1.6 2,603 1.9
1947 372,963 264.6 106,539 75.6 107,767 76.4 121,980 86.5 12,271 8.7 400,639 284.2 9,039 6.4 2 ,403 1.7 2,688 1.9
1948 338,141 234.7 80,528 55.9 97,745 67.9 123,972 86.1 13,309 9.2 363,014 252.0 8,631 6.0 2,315 1.6 2,494 1.7
1949 288,736 197.3 54,248 37.1 84,331 57.6 121,931 83.3 14,295 9.8 331,661 226.7 7,218 4.9 2 ,611 1.8 2,170 1.5
1950 229,723 154.2 32,148 21.6 64,786 43.5 112,424 75.5 13,446 9.0 303,992 204.0 5,796 3.9 2,017 1.4 1,635 1.1
1951 198,640 131.8 18,211 12.1 52,309 34.7 107,133 71.1 12,836 8.5 270,459 179.5 5,707 3.1 1,637 1.1 1,332 .9
1952 168,734 110.8 11,991 7.9 38,365 25.2 101,920 66.9 9,240 6.1 245,633 161.3 3,837 2.5 1,069 .7 1,235 .8
1953 156,099 100.8 9,551 6.2 32,287 20.8 100,195 64.7 8,021 5.2 243,857 157.4 3,490 2.3 785 .5 1,103 .7
1954 137,876 87.5 7,688 4.9 24,999 15.9 93,601 59.4 7,234 4.6 239,661 152.0 3,294 2.1 607 .4 917 .6
1955 122,075 76.0 6,516 4.1 21,553 13.4 84,741 52.7 5,515 3.4 239,787 149.2 2,863 1.8 584 .4 875 .5
1956 126,219 77.1 6,757 4.1 20,014 12.2 89,851 54.8 5,535 3.4 233,333 142.4 2,322 1.4 419 .3 602 .4
1957 130,552 78.3 6,251 3.8 19,046 11.4 96,856 58.1 5,452 3.3 216,476 129.8 1,860 1.1 348 .2 449 .3
1958 116,630 68.5 6,661 3.9 16,698 9.8 85,974 50.5 4,839 2.8 220,191 129.3 1,574 .9 332 .2 436 .3
1959 119,981 69.3 8,178 4.7 17,592 10.2 86,776 50.1 5,215 3.0 237,318 137.1 1,604 .9 282 .2 485 .3
1960 120,249 68.0 12,471 7.1 16,829 9.5 84,195 47.6 4,593 2.6 246,697 139.6 1,555 .9 273 .2 800 .5
1961 125,262 69.7 18,781 10.4 19,146 10.7 80,942 45.0 4,388 2.4 265,665 147.8 1,595 .9 296 .2 842 .5
1962 124,188 68.1 20,084 11.0 19,924 10.9 78,264 42.9 4,085 2.2 260,468 142.8 1,401 .8 203 .1 635 .3
1963 128,450 69.3 22,045 11.9 18,683 10.1 81,736 44.1 4,140 2.2 270,076 145.7 1,242 .7 196 .1 589 .3
1964 118,247 62.9 22,733 12.1 18,104 9.6 72,184 38.4 3,737 2.0 290,603 154.5 1,260 .7 145 .1 543 .3
1965 113,018 59.7 23,250 12.3 17,315 9.1 67,636 35.7 3,505 1.9 310,155 163.8 1,083 .6 144 .1 873 .5
1966 110,128 57. 1 22 ,M l 11.6 16,974 8.8 66,149 34.3 3,464 1.8 334,949 173.6 950 .5 164 . 1 625 .3
1967 103,546 53.2 21.09C 10.8 15,618 8.0 62,653 32.2 3,050 1.6 375,606 193.0 787 .4 128 . 1 380 .2
1968 98,195 49.9 20,182 10.3 15,379 7.8 58,905 29.9 2,596 1.3 431,380 219.2 827 .4 174 .1 349 .2
^Includes "Stage of Syphilis Not Stated."
TABLE 5a





1957 1965 1967 1968
Cases Percent Cases Percent Cases Percent Cases Percent
0 - 1 Year 180 3.3 373 10.6 398 13.1 327 12.6
1 - 4  Years 79 1.4 59 1.7 26 0.9 30 1.2
5 - 9  Years 190 3.5 44 1.3 37 1.2 28 1.1
10 Yeari and Over 5 ,003 91.8 3,029 86.4 2,589 84.8 2,211 85.1
GRAND TOTAL 5 ,452 100.0 3,505 100.0 3,050 100.0 2,596 100.0
*Approximately 90% of 
known ages.
congenital icases reported by age. Cases not reported by age have been prorated according to
TABLE 5b
REPORTED CASES OF 
Case
CONGENITAL SYPHILIS, UNDER ONE YEAR OF AGE 
Rates per 10,000 Live Births**
UNITED STATES 
SELECTED YEARS 1957-1968
1957 1965 1967 1968
Cases Rate Cases Rate Cases Rate Cases Rate
180 0.4 373 0.8 398 1.1 327 0.9
** Live births are reported in Monthly Vital Statistics Report, National Center for Health Statistics, (DHEW-PHS)
TNFAÌST MORTALXTf W E  TO SYPH IL IS  - See T a b le  2 .
TABLE 6
REPORTED VENEREAL DISEASE CASES AND CASE RATES PER 100,000 POPULATION*
UNITED STATES 








Cases Rates Cases Rates Cases Rates Cases Rates
Alabama 960 27.4 681 19.4 4,565 130.3 18 .5
Alaska 41 17.2 2 .8 931 391.2 0 .0
Arizona 835 52.0 265 16.5 3,326 207.1 16 1.0
Arkansas 636 32.5 137 7.0 6,140 313.4 4 .2
California 10,515 56.0 1,543 8.2 63,783 339.4 82 .4
Colorado 484 25.1 31 1.6 2,570 133.5 2 .1
Connecticut 483 16.6 91 3.1 4,263 146.4 2 .1
Delaware 545 105.8 59 11.5 1,534 297.9 4 .8
Dist. of Columbia 2,060 260.1 772 97.5 12,231 1544.3 148 18.7
Florida 4,017 68.1 1,851 31.4 13,996 237.2 124 2.1
Georgia 2,425 55.3 905 20.6 18,688 425.9 172 3.9
Hawaii 111 16.2 7 1.0 608 88.9 2 .3
Idaho 23 3.3 6 .9 804 115.7 0 .0
Illinois 6,919 63.9 1,178 10.9 39,326 363.3 12 .1
Indiana 1,397 28.0 305 6.1 5,855 117.4 0 .0
Iowa 772 28.1 50 1.8 3,710 134.9 5 .2
Kansas 1,072 47.6 38 1.7 3,559 157.9 8 .4
Kentucky 1,378 43.9 165 5.3 3,733 118.8 2 .1
Louisiana 2,264 62.6 785 21.7 6,307 174.3 51 1.4
Maine 341 35.6 6 .6 862 90.1 1 .1
Maryland 3,146 87.2 522 14.5 8,678 240.6 18 .5
Massachusetts 2,404 44.6 197 3.7 5,816 108.0 10 .2
Michigan 5,485 64.1 1,071 12.5 17,283 201.8 62 .7
Minnesota 164 4.6 61 1.7 3,113 87.1 1 .0
Mississippi 664 28.6 339 14.6 5,688 245.3 52 2.2
Missouri 3,529 77.3 182 4.0 11,539 252.8 68 1.5
Montana 53 7.7 9 1.3 524 75.8 1 .1
Nebraska 388 27 o 3 35 2.5 2,167 152.4 4 .3
Nevada 239 54.7 38 8.7 949 217.2 1 .2
New Hampshire 66 9.7 4 .6 416 61.1 2 .3
New Jersey 3,485 50.2 537 7.7 6,891 99.2 6 .1
New Mexico 740 75.1 167 17.0 1,880 190.9 4 .4
New York 15,145 82.8 2,325 12.7 40,194 219.6 65 .4
North Carolina 1,566 31.9 731 14.9 11,133 226.8 71 1.4
North Dakota 39 6o2 6 1.0 435
69.4 1 .2
Ohio 4,137 39.6 556 5.3 20,115 192.7 54 .5
Oklahoma 1,246 50.9 87 3.6 3,923 160.4 6 .2
Oregon
Pennsylvania
192 9.6 35 1.8 3,659 183.5 0 .0
4,346 37.4 579 5.0 13,909 119.8 19 .2
Rhode Island 629 71.9 40 4.6 837
95.7 0 .0
South Carolina 1,472 58.3 609 24.1 8,697
344.2 68 2.7
South Dakota 132 19.8 42 6.3 1,041
156.1 4 .6
Tennessee 1,153 29.9 359 9.3
12,166 315.8 21 .5
Texas 6,003 56.3 2,355 22.1 31,885 299.3 134 1.3
Utah 104 10.2 10 1.0
911 89.5 0 .0
Vermont 39 9.4 3 .7
281 67.7 0 .0
Virginia 1,720 39.6 292 6.7





















1,344 32.1 22 .5 3,551 84.9 3 . 1
65 20.9 4 1.3 188 60.5 0 .0
United States Total 98.195 49.9 20,182 10.3
431.380 219.2 1,350 .7
*Rates less than .05 not shown.
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TABLE 7
P R I M A R Y  A N D  S E C O N D A R Y  S Y P H I L I S  
M O R B I D I T Y  A N D  A G E - S P E C I F I C  C A S E  RA TE S  PER 100,  000 P O P U L A T I O N  BY  A G E - G R O U P S ,  C O L O R ,  A N D  SEX
U N I T E D  S TATE S
C a l e n d a r  Ye a r s  1956,  1 964 - 1 967
AGE YEAR
White Nonwhite ■¡total White Nonvni te Ttotal
YEAR AGE
Male Female Total Male Female Total Male Female Total Male Female Total Male Female Total Male Female Total
0-lU 1956 1* 6 10 13 55 68 17 61 78 .0 .0 .0 . 1* 1.7 1 .0 . 1 .2 .2 1956 0-lk
19 &* 10 1 1 2 1 61 210 271 71 221 292 .0 .0 .0 1 . 1* U.8 3.1 .8 .5 1961*
1965 7 8 15 73 193 266 80 201 281 .0 .0 .0 1 .6 1* . 1* 3.0 .3 .7 .5 1965
1966 5 7 12 ¿1* 166 230 69 173 2U2 .0 .0 .0 1 . 1* 3.7 2.6 .2 .6 . 1* 1966
1967 8 2 10 68 16 1 229 76 163 239 .0 .0 .0 1.5 3.5 2.5 .2 .6 . 1* 1967
15-19 195b 127 139 266 1*00 1*97 897 527 636 llo 3 2.8 2.8 2.8 59.3 68.7 61*.2 10 . 1 11.3 10.7 1956 15-19
IQbk 310 238 5^8 1317 1730 301*7 1627 1968 3595 U.6 3*1* L.O 13**.5 169.9 15 2 .5 20.9 2i*.5 22.7 196U
1965 286 2U8 531* 1 U9U 20 11 3505 1780 2259 1*039 3.9 3.** 3.7 11*2.3 18 6 .2 16U.5 2 1 .U 26.9 21*. 2 1965
1966 239 227 U66 IU92 1888 3380 1731 2115 381*6 3.2 3.0 3.1 133.2 16 3 .6 11*8.6 20.0 2l*.0 2 2 .1 1966
1967 255 190 1*1*5 1551 18 10 3361 1806 2000 3806 3.5 2.5 3.0 135.7 151.7 H*3.9 2 1 . 1* 22.8 22 .1 1967
20-2U 1956 399 138 537 739 1*82 12 2 1 113 8 620 1758 10 .9 3.0 6. 1* 13 6 .1 72.1* 1 0 1 . 1 27.0 1 1 .6 18 . 1* 1956 20-2k
1961» 989 391* 1383 2866 2206 5072 3855 2600 61*55 20.3 6.9 13 .0 1*19 .0 277.1 3**2.5 69.U 39.7 53.1* 196*1
1965 918 35U 1272 3032 2271 5303 3950 2625 6575 18 .3 5.9 1 1 .6 U26.U 273.3 3^3.9 68.9 38.7 52.5 1965
1966 7U9 325 1071* 2760 2199 1*959 3509 252U 6033 11*.9 5.3 9.7 382.8 256.0 313.7 6 1.2 36.2 1*7.5 1966
1967 798 368 1166 2825 216 1 U986 3623 2529 6 lt>2 li*. 8 5.6 9.7 370.2 236.1* 297.3 59.0 33.6 1*5.0 1967
25-29 1956 39U 10U 1*98 i*6U 301 765 858 1*05 1263 8.3 2.0 5.0 8 1 . 1 **3-5 60.5 16 . 1 6.9 11.3 1956 25-29
19bk 851 201 1052 2157 13 3 1 31*88 3008 1532 -1*51*0 18 .8 l*.l 1 1 . 1 362.5 187.5 267.3 58.6 27.2 1*2 .2 1961*
1965 750 206 956 2266 1322 3588 3016 1528 1*51*1* 16 .3 U.l 10 .0 375.8 18U.9 272.2 57.9 26.8 1*1.7 1965
1966 656 217 873 2179 1287 31*66 2835 1501* **339 li* .0 U.2 8.9 350.9 176.5 256.6 53.3 25.8 38.9 1966
1967 679 20U 883 2127 1 1 7 1 3298 2806 1375 1*181 13.7 3.8 8.6 328.2 155.5 235.1* 50.0 22.6 35.7 1967
30-39 1956 1*61 130 591 1*76 291 767 937 1*21 1358 **•5 1 . 2 2 .8 1*1 .8 2 2 .1 31.2 8 .2 3 .1* 5.7 1956 30-39
196k 1311 271 1582 2299 1281* 3583 3610 1555 5165 13-1* 2.6 7.8 191.3 89.2 135.6 32.9 1 3 . 1 22.6 196k
1965 1105 207 1312 229U 1367 3661 3399 1571* 1*973 11.5 2.0 6.6 192.9 95.6 139.8 31.** 13 .5 22 .1 1965
1966 913 2U3 115 6 2131* 1195 3329 30U7 11*38 1*1*85 9.7 2 . 1* 5.9 18 1 .5 81*.0 12 8 .1 28.7 12 .5 20.3 1966
1967 877 215 1092 2060 1139 3199 2937 1351* 1*291 9.2 2 . 1 5.6 17U.3 80.0 122 .8 27.5 1 1 .8 19.** 1967
1*0-1*9 1956 215 51* 269 153 78 231 368 132 500 2.3 .5 1 . 1* 15.1 6.9 10 .8 3.5 1 . 2 2.3 1956 ko-k9
196k 631 168 799 809 1*29 1238 11*1*0 597 2037 6.2 1.5 3.8 71.5 33.6 5 1 . 1* 12.7 »*.9 8.7 196k
1965 583 H*7 730 902 1*23 1325 IU85 570 2055 5.6 1.3 3 .1* 79.1 32.6 51*.3 13 .0 U.7 8.7 1965
1966 1*1*8 1 1 1 559 810 383 1193 1258 U9U 1752 *».3 1 .0 2.6 70.1* 29.O 1*8.3 10.9 u.o 7.3 1966
1967 U89 116 605 733 371 1101* 1222 1*87 1709 »*.7 1 .0 2.8 63 . 1* 27.5 1*1*. 1 10 .6 3.9 7.1 1967
50 + 1956 120 29 ll*9 88 38 126 208 67 275 .7 .2 . 1* 6.0 2.5 1*.2 1 . 1 .3 .7 1956 50 +
1961* 336 69 1*05 358 122 i*8o 69U 191 885 1 .8 .3 1 .0 19.3 6.0 12.3 3.3 .8 2 .0 196k
1965 266 8U 350 378 11*3 521 6U1* 227 871 l.l* . 1* .8 20 .1 6.8 13.1 3.0 .9 1 .9 1965
1966 23U 1*0 27U 311* 129 1*1*3 51*8 169 717 1 . 2 .2 .6 16 .5 6.0 10.9 2.6 .7 1 . 5 1966
1967 222 51 273 309 93 1*02 531 11*1* 675 1 . 1 .2 .6 16 .2 1*.2 9.8 2.5 .6 1 . 1* 1967
Total 1956 1720 600 2320 2333 17 U2 U075 1*053 23»*2 6395 2 . 1* .8 1 .6 26.7 18 . C 22.5 5.0 2.8 3.9 1956 Total
196k UU38 1352 5790 9367 7312 17179 1U305 866U 22969 5.5 1 .6 3.5 9 1 . 1* 62.9 76.6 15.6 8.9 1 2 . 1 196k
1965 3915 125k 5169 IOU39 7730 18169 11*351* 898U 23338 i*.8 1 . 1* 3.1 9^.7 6 5 .1 79.3 15.1* 9.1 12 .2 1965
1966 32UU 1170 1*1*11* 9753 721*7 17000 12997 81*17 211*11* 3.9 1 . 3 2.6 87.0 59.8 72.9 13.9 8. 1* 1 1 . 1 1966
1967 3328 1 1 U6 1*1*71+ 9673 6906 16579 13001 8052 21053 u.o 1 . 3 2.6 85.O 55.8 69.8 13.8 8.0 10 .8 1967
Note: Cases not reported by age have been included on the bases of the known age d is tr ib u tio n . Rates are base- on population estimates of the 
Bureau of the Census. Numbers Include Alaska and Hawaii fo r 1956 and I 96U-I967. Rates are based on cases excluding Alaska and Hawaii 
fo r 1956. For I 96U-I967 rates are based on numbers for the United S tates, inc lud ing  Alaska and Hawaii.
TABLE 8
M O R B I D I T Y  A N D  A G E - S P E C I F I C  C A S E  RATE S  PER 100,  000 P O P U L A T I O N  BY  A G E - G R O U P S ,  C O L O R ,  A N D  SEX
U N I T E D  S TATES  
C a l e n d a r  Yea r s  1956,  1 964 - 1 967
ACE-SPECIFIC CASE RATES PER 100,000 POPULATION
0-14 1956 I 30 648 778 619 2203 2822 7k9
iemale
2851
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Bureau o f the Census. Numbers include Alaska and Hawaii fo r 1956 and 196U-1967 . Rates are based on cases excluding Alaska and Hawaii 
for 1956. For I 96U-I967 rates are based on numbers for the United S tates, includ ing Alaska and Hawaii.
Health Department Caseiintlin«; Activities
Casefinding Investigations fall into two categories: (1) the investigation of sex contacts 
of patients with recently acquired and infectious disease, and (2) the investigation of persons 
other than sex contacts who are suspected of having venereal disease. Most of the latter 
group of suspects are persons with reactive tests for syphilis which are generated by the 
estimated 38,000,000 serologic tests performed annually in the United States, and are referred 
to in Table 10 as positive diagnostics. Thousands of the investigations of positive diagnostics 
and sex contacts carry health department casefinding workers into the offices of private 
physicians who make the medical determination of whether or not the suspects have syphilis.
For many years, the proficiency of the interviewing-contact investigation process in 
ferreting out the foci of syphilis infections in the community has been measured by a series 
of epidemiologic indices. The indices presented in Table 10 are based only on infectious cases 
diagnosed in health department clinics and do not include cases diagnosed and reported by 
private physicians. These indices are defined as follows:
The Contact Index is the average number of sex contacts elicited per infectious (primary 
and secondary) syphilis case interviewed.
The Epidemiologic Index is the average number of cases of syphilis identified per infec­
tious case interviewed. A number of these identified cases will already have been d iag no se d  
and treated.
The Brought-to-Treatment Index is the average number of previously not diagnosed cases 
of syphilis brought to treatment per infectious case interviewed.
The Lesion-to-Lesion Index is the average number of infectious (lesion or primary or 
secondary) cases brought to treatment per infectious case interviewed.
TABLE 9
HEALTH DEPARTMENT'CASEFINDING ACTIVITIES, UNITED STATES 
FISCAL YEARS 1963-1968
1963 1964 1965 1966 1967 1968
Number of positive diag­
nostics investigated. 243,257 241,016 245,715 257,009 231,517 223,939
Number of contacts in­



































For the treatment of very small Infants with congenital syphilis, aqueous procaine peni­
cillin G is the preferred form of penicillin, the schedule consisting of 100,000 u/kg. of body 
weight in 10 equally divided daily doses. Benzathine penicillin G in a single injection of 50,000 
u/kg. is recommended for all other children under 12 years of age or under 70 pounds in 
weight. Older or heavier children are generally treated with schedules recommended for 
adults in comparable stages of syphilis.
The earlier penicillin therapy is instituted for congenital syphilis, the more satisfactory 
the results.
Early  Syphilis
Benzathine penicillin G and procaine penicillin G in oil with 2-percent aluminum mono­
stearate (PAM) are the most widely used penicillin preparations for the treatment of early 
syphilis. Since benzathine penicillin G maintains a detectable blood level for a much longer 
period of time than PAM, a smaller total dosage is required for satisfactory results. The 
recommended schedules are 2,400,000 units of benzathine penicillin G administered in a single 
session (1,200,000 units in each buttock) or 4,800,000 units of PAM, 2,400,000 units at first 
session, and subsequent injections of 1,200,000 units given at 2- or 3-day intervals. If aqueous 
procaine penicillin G is used, 600,000 units should be administered daily for 8 days to total
4,800,000 units.
For the patient who is sensitive to penicillin, erythromycin or tetracycline in a total 
dosage of 30-40 grams administered over a 10-15 day period is recommended for the treatment 
of syphilis.
Epidemiologic Treatment
The treatment of all sex contacts of patients with early infectious syphilis is recom­
mended as the most effective procedure for preventing the spread of syphilis. Although clinically 
and serologically negative at time of initial examination, some of these contacts will have 
incubating syphilis and some, particularly females who may have an inconspicuous or no 
primary lesion, will already have developed syphilis. It is suggested, therefore, that contacts 
be treated for syphilis (rather than for incubating syphilis) with a dosage of 2,400,000 units of 
benzathine penicillin G.
Syphilis in Pregnancy
Congenital syphilis is completely preventable. Adequate treatment of the mother during 
the first 18 weeks of gestation prevents infection of the baby; adequate treatment after the 18th 
week cures the baby in utero.
In two studies, comprising 528 infants born to treated syphilitic mothers, approximately 
98 percent of the children were nonsyphilitic. The percentage varied slightly by stage of 
mother’s syphilis during pregnancy.
In the absence of relapse or reinfection, a woman treated with penicillin for syphilis 
will not require further treatment in the event of pregnancy.
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Neurosyphilis
A cooperative study conducted by the Public Health Service and leading neurosyphilolo- 
gists in the United States has demonstrated that penicillin is the most effective treatment yet 
known for neurosyphilis.
Asymptomatic Neurosyphilis — Among 765 patients with asymptomatic neurosyphilis, 
approximately 75 percent of whom were treatedwltha minimum of 4,800,000 units of penicillin, 
only one bona fide progression to symptomatic neurosyphilis was observed; 11 other patients 
exhibited minor neurologic changes. In contrast, among 467patients treated with metal chemo­
therapy, 29 progressed to symptomatic neurosyphilis and an additional 15 showed minor neuro­
logic changes.
Paresis — Six hundred and twenty-nine patients were treated for paresis with penicillin 
only, 60 percent of whom received a minimum of 6,000,000 units. Paresis was diagnosed severe 
in 330, moderately severe in 141, and mild in 158. Five years after treatment 42 percent of 
those with severe psychoses were in remission or showed significant improvement, 45 per­
cent remained unchanged, and only 13 percent had progressed or died from paresis. Progres­
sion or death from paresis occurred in 7.0 percent of those with moderately severe psychosis 
and in less than one percent of those with mild psychosis. Further proof of the effectiveness of 
penicillin is the fact that among those who survived, one-third of those who had been in­
stitutionalized, and two-thirds of those who had been unable to work at time of treatment were 
gainfully employed 5 years later.
The total recommended dosage of penicillin for both symptomatic and asymptomatic 
neurosyphilis is 6,000,000 to 9,000,000 units. Any benefit from more than 10,000,000 units is 
doubtful and has not been demonstrated. Treatment schedules are as follows:
Benzathine penicillin G — 3,000,000 units at 7-day intervals.
PAM — 1,200,000 units at 3-day intervals.
Aqueous procaine penicillin G — 600,000 units daily.
Treatment of Gonorrhea
The treatment of gonorrhea is in a state of uncertainty although penicillin still remains 
the drug of choice. Some strains of the gonococcus are developing increasing resistance to 
penicillin, but this resistance is relative and not absolute. Treatment schedules presently 
recommended are as follows:
Uncomplicated gonorrhea in men: Aqueous procaine penicillin G, 2,400,000 units in one 
IM Injection.
Uncomplicated gonorrhea in women: Aqueous procaine penicillin G, 4,800,000 units IM in 
two injection sites at one visit, or the combination of aqueous procaine penicillin G and pro­
caine penicillin G in oil with 2 percent aluminum monostearate for two separate IM injections 
of 2,400,000 units in each site given at one visit.
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Treatment of gonorrhea with severe complications must be individualized using large 
amounts of short acting penicillin.
Excluding the likelihood of reinfection, retreatment is indicated if the discharge in un­
complicated male gonorrhea persists for three or more days following initial therapy and the 
smear or culture is still positive. In uncomplicated gonorrhea in the female retreatment is in­
dicated if followup cultures remain positive for gonococci. Pie treatment consists of doubling 
the original dosage at a single visit or in divided doses on two successive days.
Prophylactic or epidemiologic treatment for gonorrhea (male and female) is accomplished
with the same treatment schedules as for uncomplicated gonorrhea.
Gonorrhea patients sensitive to penicillin may be treated effectively with tetracycline 
administered as a single oral dose of 1.5 grams. This dosage, however, is inadequate to abort 
incubating syphilis.
Gonorrhea patients who are sexual contacts to infectious syphilis should be given full 
prophylactic therapy for syphilis (2,400,000 units of benzathine penicillin G) as well as recom­
mended therapy for gonorrhea. While long acting forms of penicillin (such as benzathine 
penicillin) are ideal in syphilotherapy, they are not indicated in routine gonorrhea treatment.
Penicillin Reactions
Since penicillin is the drug of choice for the treatment of both syphilis and gonorrhea, the 
Venereal Disease Program is concerned with the frequency and severity of reactions to 
penicillin therapy. Through the cooperation of venereal disease clinics three studies at 5-year 
intervals (1954, 1959 and 1964) have been conducted to determine their frequency.
The 1959 and 1964 studies were patterned after the 1954 study, the single departure 
being a request that, if possible, patients be detained in the clinic for a 30-minute period 
following treatment. Reactions to penicillin were reported in 5.9/1,000 patients treated in 
1954, in 9.7/1,000 treated in 1959, and in 8.0/1,000 treated in 1964. The increase over 1954 is 
attributed mainly to the delay In dismissing patients after treatment.
In each study, urticaria was the most frequent type of reaction, occurring in from 
4-6/1,000 patients treated. Moderate to severe anaphylaxis was observed in 0.21 to 0.35/1,000 
patients. The only death reported during a study period occurred in 1964.
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